Specialty Utilization Disparities Among Hidradenitis Suppurativa Patients in a Retrospective Analysis of the National Ambulatory Medical Care Survey 2006-2016
Katie Roster,Ahmad Rajeh,Shari Lipner
DOI: https://doi.org/10.5826/dpc.1401a60
2024-02-01
Dermatology Practical & Conceptual
Abstract:Accepted: April 9, 2023 ; Published: January 2024 Copyright: ©2024 Roster et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: Dr. Lipner has served as a consultant for Hoth Therapeutics, Ortho Dermatologics, Moberg Pharmaceuticals, and Belle Torus Corporation. There are no conflicts of interest declared for the other authors. Authorship: All authors have contributed significantly to this publication. Keywords : Hidradenitis suppurativa, skin of color, healthcare utilization This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. References 1. Udechukwu, N. S., & Fleischer, A. B., Jr (2017). Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United States. Journal of the National Medical Association, 109(1), 44–48. https://doi.org/10.1016/j.jnma.2016.09.002 2. Khalsa, A., Liu, G., & Kirby, J. S. (2015). Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa. Journal of the American Academy of Dermatology, 73(4), 609–614. https://doi.org/10.1016/j.jaad.2015.06.053 3. Robinson, I., Lee, L., & Cotton, C. (2022). The Impact of Racial Differences on Treatment Strategies in Hidradenitis Suppurativa: A Retrospective Review. Journal of drugs in dermatology : JDD, 21(3), 270–275. https://doi.org/10.36849/JDD.6446 4. Wehner, M. R., Micheletti, R., Noe, M. H., Linos, E., Margolis, D. J., & Naik, H. B. (2020). Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. Journal of the American Academy of Dermatology, 82(5), 1239–1241. https://doi.org/10.1016/j.jaad.2019.12.030 5. Davis, S. A., Lin, H. C., Balkrishnan, R., & Feldman, S. R. (2015). Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases. Skin appendage disorders, 1(2), 65–73. https://doi.org/10.1159/000431037
dermatology